Liminatus Pharma, Inc.
LIMN
$3.84
$0.205.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 58.15% | 464.91% | -53.39% | -45.86% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -56.90% | 434.62% | -65.98% | 7.84% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 22.10% | 455.03% | -58.40% | -32.48% | -- |
|
|
|||||
| Total Current Assets | 22.10% | 455.03% | -58.40% | -32.48% | -- |
| Net Property, Plant & Equipment | -4.27% | -4.10% | -4.69% | 6,300.00% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 0.00% | -- |
| Total Assets | 21.99% | 444.11% | -61.80% | -29.67% | -- |
|
|
|||||
| Total Accounts Payable | 23.65% | -9.00% | 4.11% | 29.47% | -- |
| Total Accrued Expenses | 8.45% | 9.17% | 10.28% | 11.52% | 14,972.73% |
| Short-term Debt | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 0.98% | -91.39% | 1,090.03% | -92.00% | -- |
| Total Other Current Liabilities | 0.98% | -91.39% | 1,090.03% | -92.00% | -- |
| Total Current Liabilities | 5.23% | -71.94% | 259.50% | -72.76% | 955,872.73% |
|
|
|||||
| Total Current Liabilities | 5.23% | -71.94% | 259.50% | -72.76% | 955,872.73% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 87.72% | 14.38% | -76.38% | -38.35% | -- |
| Total Liabilities | 6.17% | -71.70% | 245.61% | -72.12% | 974,100.00% |
|
|
|||||
| Common Stock & APIC | 4.62% | 37.19% | 0.00% | 44.76% | -- |
| Retained Earnings | -3.52% | -2.89% | -26.61% | -6.31% | -2,625,309.09% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 326.70% | 98.65% | -496.35% | 81.31% | -800,572.73% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 326.70% | 98.65% | -496.35% | 81.31% | -800,572.73% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 326.70% | 98.65% | -496.35% | 81.31% | -800,572.73% |
|
|
|||||